 | • レポートコード：SRT22JL0350 • 出版社/出版日：Straits Research / 2022年5月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User | ￥570,000 (USD3,800) | ▷ お問い合わせ |
| Department License | ￥720,000 (USD4,800) | ▷ お問い合わせ |
| Corporate/Global Licence | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Straits Research社発行の当調査レポートでは、世界の治験薬受託開発製造企業（IND CDMO）市場について広範囲に分析し、市場概要、関連企業、種類別、用途別、アジア太平洋市場、ヨーロッパ市場、北米市場、南米市場、中東・アフリカ市場などの地域分析を含めた項目を掲載しています。なお、当レポートに掲載されている主要企業情報には、Covance Inc.、Charles River Laboratories Inc.、Cambrex Corporation、IQVIA Holdings Inc.、Syneos Health、Lonza、Catalent、Recipharm AB、Siegfried Holding AG、Thermo Fisher Scientific Inc.などが含まれています。 ・市場概要 ・企業情報 ・世界の治験薬受託開発製造企業（IND CDMO）市場規模：種類別 ・世界の治験薬受託開発製造企業（IND CDMO）市場規模：用途別 ・アジア太平洋の治験薬受託開発製造企業（IND CDMO）市場規模 ・ヨーロッパの治験薬受託開発製造企業（IND CDMO）市場規模 ・北米の治験薬受託開発製造企業（IND CDMO）市場規模 ・南米の治験薬受託開発製造企業（IND CDMO）市場規模 ・中東・アフリカの治験薬受託開発製造企業（IND CDMO）市場規模 |
Summary:
In this Investigational New Drug CDMO Market report, offers a comprehensive analysis of key market trends in the global Investigational New Drug CDMO market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and challenges which are backed by factful feedbacks. The report extensively provides quantitative analysis of the industry from 2022-2030, by Region, Type, Application. Consumption assessment by application, production by type in different regions. Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. The global investigational new drug CDMO market size was valued at USD 4.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.9% from 2022 to 2030. The market growth can be attributed to factors such as the increasing outsourcing services by pharmaceutical companies, rising R&D investments, and stringent regulations for conducting clinical studies
Geographically, global Investigational New Drug CDMO market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Covance Inc.
Charles River Laboratories Inc.
Cambrex Corporation
IQVIA Holdings Inc.
Syneos Health
Lonza
Catalent
Recipharm AB
Siegfried Holding AG
Thermo Fisher Scientific Inc.
Production, consumption, revenue, market share and growth rate are the key targets for Investigational New Drug CDMO from 2022 to 2030 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Reasons for Doing the Study:
This report is an update of an earlier (2022) Research study. Since the previous edition of this report was published, the Investigational New Drug CDMO market has continued to evolve. In particular, the overall market growth rates forecast in the previous edition now appear to have been too high, extending the time-line for the market’s development. In order to give its readers, the most up-to-date and accurate assessment of future market opportunities.
If you have any special requirements, please let us know and we will offer you the report as you want.
レポート目次Table of Contents
Part 1 Market Overview
1.1 Market Definition
1.2 Market Development
1.2.1 Current Situation
1.2.2 Aspects of COVID-19 Impact
1.3 By Type
Table Type of Investigational New Drug CDMO
Figure Global Investigational New Drug CDMO Market Share by Type in 2021
1.4 By Application
Table Application of Investigational New Drug CDMO
Figure Global Investigational New Drug CDMO Market Share by Application in 2021
1.5 By Region
Figure Global Investigational New Drug CDMO Market Share by Region in 2021
Figure Asia Investigational New Drug CDMO Market Share by Region in 2021
Part 2 Key Companies
2.1. Company Profile
Table Overview List
2.2 Products & Services Overview
2.3 Sales Data List
Table Investigational New Drug CDMO Business Operation of (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Part 3 Global Market Status and Future Forecast
3.1 Global Market by Region
Table Global Investigational New Drug CDMO Market by Region, 2019-2020 (Million USD)
Figure Global Investigational New Drug CDMO Market Share by Region in 2021 (Million USD)
Table Global Investigational New Drug CDMO Market by Region, 2019-2020 (Volume)
Figure Global Investigational New Drug CDMO Market Share by Region in 2021 (Volume)
Table Price List by Region, 2019-2020
3.2 Global Market by Company
Table Global Investigational New Drug CDMO Market by Company, 2019-2020 (Million USD)
Figure Global Investigational New Drug CDMO Market Share by Company in 2021 (Million USD)
Table Global Investigational New Drug CDMO Market by Company, 2019-2020 (Volume)
Figure Global Investigational New Drug CDMO Market Share by Company in 2021 (Volume)
Table Price List by Company, 2019-2020
3.3 Global Market by Type
Table Global Investigational New Drug CDMO Market by Type, 2019-2020 (Million USD)
Figure Global Investigational New Drug CDMO Market Share by Type in 2021 (Million USD)
Table Global Investigational New Drug CDMO Market by Type, 2019-2020 (Volume)
Figure Global Investigational New Drug CDMO Market Share by Type in 2021 (Volume)
Table Price List by Type, 2019-2020
3.4 Global Market by Application
Table Global Investigational New Drug CDMO Market by Application, 2019-2020 (Million USD)
Figure Global Investigational New Drug CDMO Market Share by Application in 2021 (Million USD)
Table Global Investigational New Drug CDMO Market by Application, 2019-2020 (Volume)
Figure Global Investigational New Drug CDMO Market Share by Application in 2021 (Volume)
Table Price List by Application, 2019-2020
3.5 Global Market by Forecast
Figure Global Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Global Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
Part 4 Asia-Pacific Market Status and Future Forecast
4.1 Asia-Pacific Market by Type
Table Asia-Pacific Investigational New Drug CDMO Market by Type, 2019-2020 (Million USD)
Figure Asia-Pacific Investigational New Drug CDMO Market Share by Type in 2021 (Million USD)
Table Asia-Pacific Investigational New Drug CDMO Market by Type, 2019-2020 (Volume)
Figure Asia-Pacific Investigational New Drug CDMO Market Share by Type in 2021 (Volume)
Table Price List by Type, 2019-2020
4.2 Asia-Pacific Market by Application
Table Asia-Pacific Investigational New Drug CDMO Market by Application, 2019-2020 (Million USD)
Figure Asia-Pacific Investigational New Drug CDMO Market Share by Application in 2021 (Million USD)
Table Asia-Pacific Investigational New Drug CDMO Market by Application, 2019-2020 (Volume)
Figure Asia-Pacific Investigational New Drug CDMO Market Share by Application in 2021 (Volume)
Table Price List by Application, 2019-2020
4.3 Asia-Pacific Market by Geography
4.3.1 China Market Status and Future Forecast
Figure China Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure China Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure China Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure China Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
4.3.2 Southeast Asia Market Status and Future Forecast
Figure Southeast Asia Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Southeast Asia Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Southeast Asia Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Southeast Asia Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
4.3.3 India Market Status and Future Forecast
Figure India Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure India Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure India Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure India Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
4.3.4 Japan Market Status and Future Forecast
Figure Japan Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Japan Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Japan Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Japan Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
4.3.5 Korea Market Status and Future Forecast
Figure Korea Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Korea Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Korea Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Korea Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
4.3.6 Oceania Market Status and Future Forecast
Figure Oceania Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Oceania Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Oceania Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Oceania Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
4.4 Asia-Pacific Market by Forecast
Figure Asia-Pacific Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Asia-Pacific Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
Part 5 Europe Market Status and Future Forecast
5.1 Europe Market by Type
Table Europe Investigational New Drug CDMO Market by Type, 2019-2020 (Million USD)
Figure Europe Investigational New Drug CDMO Market Share by Type in 2021 (Million USD)
Table Europe Investigational New Drug CDMO Market by Type, 2019-2020 (Volume)
Figure Europe Investigational New Drug CDMO Market Share by Type in 2021 (Volume)
Table Price List by Type, 2019-2020
5.2 Europe Market by Application
Table Europe Investigational New Drug CDMO Market by Application, 2019-2020 (Million USD)
Figure Europe Investigational New Drug CDMO Market Share by Application in 2021 (Million USD)
Table Europe Investigational New Drug CDMO Market by Application, 2019-2020 (Volume)
Figure Europe Investigational New Drug CDMO Market Share by Application in 2021 (Volume)
Table Price List by Application, 2019-2020
5.3 Europe Market by Geography
5.3.1 Germany Market Status and Future Forecast
Figure Germany Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Germany Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Germany Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Germany Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
5.3.2 UK Market Status and Future Forecast
Figure UK Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure UK Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure UK Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure UK Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
5.3.3 France Market Status and Future Forecast
Figure France Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure France Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure France Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure France Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
5.3.4 Italy Market Status and Future Forecast
Figure Italy Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Italy Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Italy Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Italy Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
5.3.5 Russia Market Status and Future Forecast
Figure Russia Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Russia Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Russia Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Russia Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
5.3.6 Spain Market Status and Future Forecast
Figure Spain Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Spain Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Spain Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Spain Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
5.3.6 Netherlands Market Status and Future Forecast
Figure Netherlands Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Netherlands Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Netherlands Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Netherlands Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
5.3.7 Turkey Market Status and Future Forecast
Figure Turkey Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Turkey Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Turkey Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Turkey Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
5.3.6 Switzerland Market Status and Future Forecast
Figure Switzerland Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Switzerland Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Switzerland Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Switzerland Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
5.4 Europe Market by Forecast
Figure Europe Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Europe Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
Part 6 North America Market Status and Future Forecast
6.1 North America Market by Type
Table North America Investigational New Drug CDMO Market by Type, 2019-2020 (Million USD)
Figure North America Investigational New Drug CDMO Market Share by Type in 2021 (Million USD)
Table North America Investigational New Drug CDMO Market by Type, 2019-2020 (Volume)
Figure North America Investigational New Drug CDMO Market Share by Type in 2021 (Volume)
Table Price List by Type, 2019-2020
6.2 North America Market by Application
Table North America Investigational New Drug CDMO Market by Application, 2019-2020 (Million USD)
Figure North America Investigational New Drug CDMO Market Share by Application in 2021 (Million USD)
Table North America Investigational New Drug CDMO Market by Application, 2019-2020 (Volume)
Figure North America Investigational New Drug CDMO Market Share by Application in 2021 (Volume)
Table Price List by Application, 2019-2020
6.3 North America Market by Geography
6.3.1 United States Market Status and Future Forecast
Figure United States Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure United States Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure United States Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure United States Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
6.3.2 Canada Market Status and Future Forecast
Figure Canada Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Canada Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Canada Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Canada Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
6.3.3 Mexico Market Status and Future Forecast
Figure Mexico Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Mexico Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Mexico Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Mexico Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
6.4 North America Market by Forecast
Figure North America Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure North America Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
Part 7 South America Market Status and Future Forecast
7.1 South America Market by Type
Table South America Investigational New Drug CDMO Market by Type, 2019-2020 (Million USD)
Figure South America Investigational New Drug CDMO Market Share by Type in 2021 (Million USD)
Table South America Investigational New Drug CDMO Market by Type, 2019-2020 (Volume)
Figure South America Investigational New Drug CDMO Market Share by Type in 2021 (Volume)
Table Price List by Type, 2019-2020
7.2 South America Market by Application
Table South America Investigational New Drug CDMO Market by Application, 2019-2020 (Million USD)
Figure South America Investigational New Drug CDMO Market Share by Application in 2021 (Million USD)
Table South America Investigational New Drug CDMO Market by Application, 2019-2020 (Volume)
Figure South America Investigational New Drug CDMO Market Share by Application in 2021 (Volume)
Table Price List by Application, 2019-2020
7.3 South America Market by Geography
7.3.1 Brazil Market Status and Future Forecast
Figure Brazil Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Brazil Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Brazil Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Brazil Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
7.3.2 Argentina Market Status and Future Forecast
Figure Argentina Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Argentina Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Argentina Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Argentina Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
7.3.3 Columbia Market Status and Future Forecast
Figure Columbia Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Columbia Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Columbia Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Columbia Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
7.3.4 Chile Market Status and Future Forecast
Figure Chile Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Chile Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Chile Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Chile Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
7.3.5 Peru Market Status and Future Forecast
Figure Peru Investigational New Drug CDMO Market Market Status, 2019-2020 (Million USD)
Figure Peru Investigational New Drug CDMO Market Market Status, 2019-2020 (Volume)
Figure Peru Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure Peru Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
7.4 South America Market by Forecast
Figure South America Investigational New Drug CDMO Market Forecast, 2022-2030 (Million USD)
Figure South America Investigational New Drug CDMO Market Forecast, 2022-2030 (Volume)
Part 8 Middle East & Africa Market Status and Future Forecast
8.1 Middle East & Africa Market by Type
Table Middle East & Africa Investigational New Drug CDMO Market by Type, 2019-2020 (Million USD)
Figure Middle East & Africa Investigational New Drug CDMO Market Share by Type in 2021 (Million USD)
Table Middle East & Africa Investigational New Drug CDMO Market by Type, 2019-2020 (Volume)
Figure Middle East & Africa Investigational New Drug CDMO Market Share by Type in 2021 (Volume)
Table Price List by Type, 2019-2020
8.2 Middle East & Africa Market by Application
Table Middle East & Africa Investigational New Drug CDMO Market by Application, 2019-2020 (Million USD)
Figure Middle East & Africa Investigational New Drug CDMO Market Share by Application in 2021 (Million USD)
Table Middle East & Africa Investigational New Drug CDMO Market by Application, 2019-2020 (Volume)
Figure Middle East & Africa Investigational New Drug CDMO Market Share by Application in 2021 (Volume)
Table Price List by Application, 2019-2020
8.3 Middle East & Africa Market by Geography
低分子イノベーターCDMOの世界市場2022年-2030年 Summary: In this Small Molecule Innovator CDMO Market report, offers a comprehensive analysis of key market trends in the global Small Molecule Innovator CDMO market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and challenges w…- 医薬品有効成分CDMOの世界市場2022年-2030年 Summary: In this Active Pharmaceutical Ingredients CDMO Market report, offers a comprehensive analysis of key market trends in the global Active Pharmaceutical Ingredients CDMO market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunitie…
- 先進治療薬CDMO（受託開発製造）の世界市場2022年-2030年 Summary: In this Advanced Therapy Medicinal Products CDMO Market report, offers a comprehensive analysis of key market trends in the global Advanced Therapy Medicinal Products CDMO market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportun…
- 注入型ドラッグデリバリーの世界市場2022年-2030年 Summary: In this Injectable Drug Delivery Market report, offers a comprehensive analysis of key market trends in the global Injectable Drug Delivery market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and challenges which are b…
- cGMPプロセス開発のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global cGMP Process Development Market The global cGMP Process Development market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Microbial cGMP Manuf…